Spadac Boosts Risk Software With Disease Tracker
Spadac Inc. said it has enhanced its suite of risk analysis software products with the acquisition of Veratect Corp.’s intellectual property assets for the tracking of infectious diseases.
Terms of the deal were not disclosed.
Spadac, founded in 2002 and based in McLean, Va., offers “geospatial intelligence services” and predictive analytics to the defense, intelligence and homeland security markets. It said Veratect’s technology can track more than 225 infectious diseases.
“Globally forecasting threats and risks is a core competency” for Spadac, Chief Executive Mark Dumas said in a statement, “and it just made sense to add a biosurveillance layer to our offerings.”
Spadac is backed by investors including FirstMark Capital and GeoEye Inc.